尿毒症性ピーク2aとグアニジノ化合物との血しょう,尿中濃度の比較検討

書誌事項

タイトル別名
  • Comparative studies of plasma and urine levels between uremic peak 2a and guanidino compounds.

抄録

Uremic peak 2a in high performance liquid chromatography analysis of uremic plasma has already been reported in relation to uremic symptom and progression of renal failure. Inorder to study mechanism of production and excretion of peak 2a, 2a levels in plasma and in urine were compared with those of creatinine (Cr) and guanidino compounds in patients undergoing conservative therapy and hemodialysis, in this paper. With progression of renal failure, 2a levels increased exponentially in plasma, but did not much change in urine. This pattern resembled with that of guanidine, but different from those of Cr, guanidinosuccinic acid (GSA), methyl guanidine (MG) and guanidinoacetic acid (GAA), i. e., Cr, increase in plasma, decrease in urine; GSA and MG, increase both in plasma and urine ; GAA, small change in plasma, decrease in urine. Production of 2a was suggested to increase in renal failure, however its main production organ did not seem to be kidney. Ratio of clearance of 2a to Cr was found to be larger than unity in initial stage of renal failure, indicating existence of tubular excretion of 2a. The ratio rapidly decreased with progression of renal failure. Similar tendency was observed in GSA and GAA, however their clearance ratios to Cr were not correlated with that of 2a, therefore excretion mechanism was thought to be different between 2a and GSA.

収録刊行物

詳細情報 詳細情報について

  • CRID
    1390282679834597632
  • NII論文ID
    130004169334
  • DOI
    10.14842/jpnjnephrol1959.29.485
  • ISSN
    18840728
    03852385
  • PubMed
    3656706
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • PubMed
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ